India’s Defense Minister Rajnath Singh at the National War Memorial to pay homage to the fallen heroes on the occasion of Kargil Vijay Diwas, in New Delhi on July 26. (ANI photo) NEW DELHI/WASHINGTON ...
Harpoon Therapeutics has given up on its onetime lead prospect HPN424. A phase 1/2a prostate cancer clinical trial found the PSMA-targeting T-cell engager had “modest activity with a tolerability ...
FORT WASHINGTON, Maryland – The Harpoon Block II+ missile completed another major flight test May 17, setting the stage for upcoming operational tests in another month, says Capt. Jaime Engdahl, U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results